| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Avacta signs distribution agreement with ABCAM for Covid-19 Affimer reagents
StockMarketWire.com
|
Cancer therapies and diagnostics group Avacta entered into a global distribution agreement with ABCAM to sell the company'sSARS-CoV-2 research Affimer reagents.
Under the worldwide, non-exclusive distribution agreement, ABCAM would enable the global research community to access Avacta's SARS-CoV-2 spike protein Affimer research reagents through its on-line catalogue.
At 9:26am: (LON:AVCT) Avacta Group PLC share price was 0p at 111.5p
Story provided by StockMarketWire.com
|
|
|
|
|
|
